— Know what they know.
Not Investment Advice
Also trades as: 0QLQ.L (LSE) · $vol 1M · YPHDF (OTC) · $vol 0M

YPSN.SW SIX

Ypsomed Holding AG
1W: -0.7% 1M: -12.1% 3M: -0.3% YTD: +18.9% 1Y: -12.5% 3Y: +40.9% 5Y: +150.7%
CHF 357.80 ($431.29)
-3.00 (-0.83%)
 
Weekly Expected Move ±4.4%
CHF 326 CHF 342 CHF 358 CHF 373 CHF 389
SIX · Healthcare · Medical - Specialties · Tech Score Sell · Power 37 · CHF 4.7B mcap · 4M float · 0.409% daily turnover

Income Trends

Revenue
$731M -2.4% ▼
5Y CAGR: +12.6%
Gross Profit
$315M +7.7% ▲
5Y CAGR: +27.1%
Operating Income
$246M +118.1% ▲
5Y CAGR: +92.7%
Net Income
$222M +153.6% ▲
5Y CAGR: +107.2%
EPS (Diluted)
$16.30 +154.3% ▲
5Y CAGR: +104.1%
EBITDA
$326M +71.0% ▲
5Y CAGR: +38.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$465M$497M$548M$749M$731M
YoY Growth+15.2%+7.0%+10.3%+36.5%-2.4%
Cost of Revenue$351M$357M$359M$457M$416M
Gross Profit$114M$141M$189M$292M$315M
Gross Margin24.5%28.3%34.5%39.0%43.0%
R&D Expenses$22M$29M$30M$34M$40M
SG&A Expenses$89M$103M$108M$126M$90M
Operating Expenses$85M$80M$103M$179M$69M
Operating Income$29M$61M$86M$113M$246M
Operating Margin6.1%12.2%15.7%15.1%33.7%
Interest Expense$2M$2M$5M$7M$3M
Income Before Tax$26M$57M$82M$104M$241M
Tax Expense$2M$5M$4M$17M$19M
Net Income$23M$51M$78M$88M$222M
Net Margin5.0%10.3%14.3%11.7%30.4%
EPS (Diluted)$1.83$3.82$5.74$6.41$16.30
EBITDA$97M$138M$162M$191M$326M
Shares Outstanding13M13M14M14M14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms